Detalhe da pesquisa
1.
Chidamide Induces Epstein-Barr Virus (EBV) Lytic Infection and Acts Synergistically with Tenofovir to Eliminate EBV-Positive Burkitt Lymphoma.
J Pharmacol Exp Ther
; 387(3): 288-298, 2023 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37875309
2.
l-Asparaginase synergizes with etoposide via the PI3K/Akt/mTOR pathway in Epstein-Barr virus-positive Burkitt lymphoma.
J Biochem Mol Toxicol
; 36(8): e23117, 2022 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-35757978
3.
The Acetyltransferase KAT5 Inhibitor NU 9056 Promotes Apoptosis and Inhibits JAK2/STAT3 Pathway in Extranodal NK/T Cell Lymphoma.
Anticancer Agents Med Chem
; 22(8): 1530-1540, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503423
4.
Risk stratification model based on VEGF and International Prognostic Index accurately identifies low-risk diffuse large B-cell lymphoma patients in the rituximab era.
Int J Hematol
; 114(2): 189-198, 2021 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33893987